STOCK TITAN

Regional Health Properties lifts preferred buyback cap to 1M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Regional Health Properties, Inc. (RHEP) appointed Robert M. Thornton, Jr. to its board effective November 11, 2026, filling the vacancy following C. Christian Winkle’s resignation. Thornton, the company’s Executive Vice President – Corporate Strategy, joins a seven-member board and will serve until the next annual meeting and until a successor is duly elected and qualified, or until his earlier death, resignation or removal. The board had not determined committee assignments; no additional compensation or equity awards were approved.

RHEP increased the Series B preferred-stock repurchase authorization to 1,000,000 shares from 500,000, an increase of 500,000 shares that includes shares previously repurchased. Repurchases may occur through open-market purchases, privately negotiated transactions, block trades or other transactions, including under Rule 10b5-1 plans. The program does not require RHEP to acquire a particular number of shares and may be modified, suspended or terminated by the board. The company expects to use available cash, subject to liquidity needs and other capital allocation priorities.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Board size after appointment 7 directors Following Robert M. Thornton, Jr.’s appointment
Aggregate Series B preferred-stock repurchase authorization 1,000,000 shares Includes shares previously repurchased
Previous aggregate repurchase authorization 500,000 shares Authorization before the increase
Increase in repurchase authorization 500,000 shares Approved November 11, 2026
12.5% Series B Cumulative Redeemable Preferred Stock financial
"its 12.5% Series B Cumulative Redeemable Preferred Stock"
Rule 10b5-1 regulatory
"trading plans adopted in accordance with Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
block trades financial
"privately negotiated transactions, block trades or other transactions"
A block trade is a single, large buy or sell of shares or bonds arranged privately between big traders rather than piecemeal on the public market. Think of it like buying a whole shipment at once instead of many small shopping trips; it lets large holders move big positions with less immediate disruption but can signal strong buying or selling pressure and cause price swings once the trade is known, so investors watch block trades for clues about market sentiment and liquidity.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RHEP Series B preferred shares are authorized for repurchase?

The program’s aggregate authorization is now 1,000,000 shares, up from 500,000. The authorization includes shares previously repurchased, and the program does not obligate RHEP to acquire a particular number of shares.

Who joined the RHEP board?

Robert M. Thornton, Jr., the company’s Executive Vice President – Corporate Strategy, was appointed effective November 11, 2026. He will serve until the next annual meeting and until a successor is duly elected and qualified, or until his earlier death, resignation or removal.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001004724false00010047242026-11-112026-11-11

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): November 11, 2026

Regional Health Properties, Inc.

(Exact Name of Registrant as Specified in its Charter)

Georgia

001-33135

81-5166048

(State or Other Jurisdiction

(Commission

(I.R.S. Employer

of Incorporation)

File Number)

Identification No.)

1050 Crown Pointe Parkway

Suite 720

Atlanta, Georgia 30338

(Address of Principal Executive Offices, and Zip Code)

(678) 869-5116

(Registrant’s telephone number, including area code)

Not applicable.

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).


Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 11, 2026, the Board of Directors (the "Board") of Regional Health Properties, Inc. (the "Company"), acting pursuant to its authority under the Company's governing documents, appointed Robert M. Thornton, Jr. to fill the existing vacancy on the Board resulting from the resignation of C. Christian Winkle. Mr. Thornton's appointment was effective November 11, 2026. Following Mr. Thornton's appointment, the Board consists of seven directors. Mr. Thornton will serve until the Company's next annual meeting of shareholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal.

 

As of the date of this report, the Board has not determined whether Mr. Thornton will serve on any committees of the Board.

 

Mr. Thornton, age 78, has served as the Company's Executive Vice President – Corporate Strategy since August 14, 2025, following the completion of the Company's merger with SunLink Health Systems, Inc. ("SunLink"). Prior to the merger, Mr. Thornton served as Chairman and Chief Executive Officer of SunLink since 1998 and as its President since July 1996. Mr. Thornton also served as SunLink's Chief Financial Officer from July 1997 through August 2002.

Mr. Thornton brings significant experience in healthcare operations, corporate strategy, acquisitions and capital allocation, which the Company believes will contribute to the Board's oversight of its integrated healthcare platform and long-term strategic initiatives.

There are no arrangements or understandings between Mr. Thornton and any other person pursuant to which he was selected as a director. Except as previously disclosed in the Company's filings with the Securities and Exchange Commission, there are no transactions involving Mr. Thornton requiring disclosure pursuant to Item 404(a) of Regulation S-K.

 

Mr. Thornton's existing employment agreement with the Company, entered into in connection with the SunLink merger on August 14, 2025, remains in effect. No additional compensation arrangements or equity awards were approved in connection with his appointment to the Board.

 

Item 8.01. Other Events.

Increase of Series B Preferred Stock Repurchase Program

On November 11, 2026, the Board approved an increase in the aggregate number of shares authorized for repurchase under the Company's previously announced stock repurchase program (the "Repurchase Program") for its 12.5% Series B Cumulative Redeemable Preferred Stock (the "Series B Preferred Stock").

 

The amendment increases the aggregate number of shares of Series B Preferred Stock authorized for repurchase under the Repurchase Program from 500,000 shares to 1,000,000 shares, representing an increase of 500,000 shares over the original authorization approved by the Board on November 25, 2025. The increased authorization includes shares previously repurchased pursuant to the Repurchase Program.

The Repurchase Program authorizes the Company to repurchase shares of its Series B Preferred Stock from time to time through open-market purchases, privately negotiated transactions, block trades or other transactions, including


pursuant to trading plans adopted in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, in each case subject to applicable securities laws.

The timing, number and price of shares repurchased will depend on market conditions, the trading price of the Series B Preferred Stock, available liquidity, regulatory requirements and other factors deemed relevant by the Company. The Special Committee of the Board will continue to oversee the timing, nature, amount and conduct of repurchases under the Repurchase Program.

The Repurchase Program does not obligate the Company to acquire any particular number of shares and may be modified, suspended or terminated at any time at the discretion of the Board. The Repurchase Program will continue until the authorized number of shares has been repurchased, unless earlier modified, suspended or terminated by the Board.

The Company expects to fund repurchases through available cash resources, subject to its liquidity needs and other capital allocation priorities.

The Board believes that the expanded Repurchase Program provides the Company with additional flexibility to manage its capital structure and pursue opportunities that may enhance long-term shareholder value.

 

 

 

Item 9.01. Financial Statements and Exhibits.

(d) Exhibit

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

REGIONAL HEALTH PROPERTIES, INC.

Date:

November 19, 2026

By:

/s/ Brent Morrison

Brent Morrison

Chief Executive Officer and President


Filing Exhibits & Attachments

1 document

Keep reading